A Phase 1/2 trial showed mostly mild to moderate and transient side effects with ALK’s peanut allergy vaccine candidate.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/alk-enters-phase-2-after-positive-results-for-peanut-allergy-vaccine/
ALK enters Phase 2 after positive results for peanut allergy vaccine
赞 (0)
关于作者
相关推荐
-
Why account-based expansion is B2B’s next growth lever
Having problem with increasing procurement expenses? Open concealed profits by changing your ABM strategy to concentrate on account-based development.The message Why account-based …
-
IRA played a role in Kemerton curtailment
Item from the plant not satisfying individual retirement account regulations .
-
Chef Robotics CEO: ‘A lot of robotics companies have made grandiose promises, but they haven’t really shipped any robots. We’re much more practical’
Robotics and automation are rarely contemporary in meals production, says Chef Robotics founder Rajat Bhageria. “The self-discipline with musty automation is that it’s no longer flexible.” Historically, observes Bhageria, who has been conserving a low profile since founding his AI-powered robotics startup in 2019, robots were designed to automate narrate tasks in ‘low mix’ production
-
ARENA tips $10M into iron ore fast charger
Initial cash offered under the $400M Industrial Makeover Stream of the Powering the Regions Fund .
-
Mexican Peso falls on rumors of Lighthizer trade appointment
The Mexican Peso (MXN) drops in its crucial sets on Monday after finishing recently on an unfavorable note …Read More
